drugset / Trial / NCT01573442

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

NCT01573442

RandomizedParallel-groupDouble-blindSupportive care

Summary

This randomized phase III trial studies testosterone to see how well it works compared to placebo in treating postmenopausal patients with arthralgia (joint pain) caused by anastrozole or letrozole. Testosterone may help relieve moderate or severe arthralgia associated with the use of aromatase inhibitors, such as anastrozole or letrozole.

Timeline

Start
2013-09-10
Primary completion
2018-02-28
Completion
2019-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 10.4 mg Subcutaneous